| Overview |
| bsm-90248r-50µL |
| GTF2I Recombinant Antbody Kit (KD-Validated) |
| WB, FCM, IC |
| Knockdown Validated |
| Human, Mouse, Rat |
| Specifications |
| Unconjugated |
| Rabbit |
| A synthesized peptide derived from human GTF2I |
| 50-150/998 |
| Recombinant |
| IgG |
| Lot dependent |
| Affinity Purified |
| 0.01M TBS (pH 7.4), 1% BSA, 0.02% Proclin 300, and 50% Glycerol |
| -20 °C |
| Target |
| 2969 |
| P78347 |
| GTF2I; General Transcription Factor IIi; TFII-I; SPIN; BAP-135; BTKAP1; WBSCR6; IB291; DIWS; Bruton Tyrosine Kinase-Associated Protein 135; General Transcription Factor II-I; SRF-Phox1-Interacting Protein; GTFII-I; BAP135; Williams-Beuren Syndrome Chromosomal Region 6 Protein; Williams-Beuren Syndrome Chromosome Region 6; General Transcription Factor II I; BTK-Associated Protein 135kD; BTK-Associated Protein 135; WBS |
| Cell Line: Hela Knockdown technology: shRNA Knockdown |
| Application Dilution |
| WB |
1:300-5000 |
| FCM |
1:20-100 |
| IC |
1:1000 |